pyridoxinedoxylamine sold brand name diclectin among others combination pyridoxine hydrochloride vitamin doxylamine succinate generally used nausea vomiting pregnancy morning sickness even though efficacy proven subsequent research led removal recommendations medical combination pyridoxine commonly referred vitamin doxylamine may effective management nausea vomiting recommended use small number cases lifestyle diet vitamin review found benefit doxylamine pyridoxine pregnancy compatible consistent fdas safety assessment combination product categorized fda category drug evidence risk fetus letter classification system risk pregnancy longer utilized currently phased american congress obstetricians gynecologists acog states safe effective treatments available severe cases mild cases nausea vomiting pregnancy may resolved lifestyle dietary american family medicine recommends initial treatment conservative includes dietary changes emotional support vitamin treatment grade consistent goodquality patientoriented evidence addition prescribing doxylamine grade c consensus diseaseoriented evidence usual practice expert opinion case canadian family physician issued correction stating previous articles stated diclectin used first line therapy incorrect based upon undisclosed conflicts interest manufacturer peerreviewed studies recommendations articles published canadian family physician nausea vomiting pregnancy evidencebased treatment algorithm treatment nausea vomiting pregnancy updated algorithm subsequently come critical scrutiny articles subjected standard peer review canadian family physician acknowledges upon closer inspection articles provide satisfactory evidence would justified recommendation doxylaminepyridoxine sole firstline treatment nausea vomiting pregnancy nvp recent canadian nvp guidelines published however subsequent reanalysis questions conclusions studies cited guidelines justify doxylaminepyridoxine recommended firstline treatment nvp additionally articles canadian family physician undisclosed conflict interest duchesnay manufacturer diclectin combination doxylaminepyridoxine canadian family physician encourages readers interpret previously published nvp recommendations caution readers also referred commentary motherisk canadian family physician january issue canadian family ed bolding help summarize information note please follow link article see footnotes article pyridoxine vitamin watersoluble vitamin generally recognized adverse diet changes alone recommended secondary treatment plan commonly reported adverse reaction doxylamine adverse drug reactions associated doxylamine succinate may include vertigo nervousness epigastric pain headache palpitation diarrhea disorientation irritability convulsions urinary retention recommended take doxylamine medications class medications act central nervous system cns alcohol may increase risk adverse minimize risk particular adverse effects doxylamine used taking medication classified monoamine oxidase inhibitor maoi used caution certain medical conditions doxylamine small enough molecular weight basis pass breastmilk women breastfeed using products doxylamine may lead adverse effects breastfed due extensive scientific evidence demonstrating difference risk birth defects adverse pregnancy outcomes infants whose mothers take pyridoxinedoxylamine pregnancy infants whose mothers take drug combination two ingredients drug considered pregnancy category drugs previous pregnancy risk factor classification system since million women used combination drug pyridoxinedoxylamine pregnancy scientific analysis exposed pregnancies conducted determine combination pyridoxine doxylamine harmful unborn epidemiological studies found teratogenic two separate metaanalyses conducted assessed pregnancy outcomes following use combination pyridoxine doxylamine without dicyclomine first trimester initial metaanalysis published combined data cohort casecontrol subsequent metaanalysis published combined data cohort studies case control studies included bendectinexposed pregnancies observe increased risk major separate analyses conducted specific defects including cardiac defects limb reduction defects oral clefts genital tract malformations increased risks defects report safety drug combination pyridoxinedoxylamine use management nvp prepared panel canadian american experts special advisory committee reproductive physiology health protection branch health canada currently called health products food scientific experts concluded numerous studies animals humans reported scientific medical literature demonstrate bendectin teratogen safety bendectindiclectin management nausea vomiting pregnancy established use many thousands pregnant women study conducted determine whether combination drug pyridoxine doxylamine effect neurodevelopment children exposed utero results study observed difference intelligence quotient scores children exposed pyridoxinedoxylamine utero children combination doxylamine vitamin first introduced us market bendectin time bendectin ingredients prescription medication third one dicyclomine pregnancy category b anticholinergicantispasmodic omitted formulation starting due lack bendectin doxylaminevitamin voluntarily removed market manufacturer merrell dow pharmaceuticals following numerous lawsuits alleging caused birth defects although fda panel concluded association bendectin birth defects litigation bendectin implicated cause various fetal malformations problems including limb musculoskeletal deformities facial brain damage defects respiratory gastrointestinal cardiovascular genitalurinary systems blood disorders famous case involving drug daubert v merrell dow pharmaceuticals suits led celebrity plaintiff attorney melvin belli star witness case bendectin william mcbride later found falsified research teratogenic effects drug struck medical register extensive review evidence submitted legal proceedings regarding bendectin summarized found evidence drug clinical use linked birth fda published statement federal register summarized opinion regarding safety pyridoxinedoxylamine pregnancy fda determined drug product bendectin tablet composed pyridoxine hydrochloride mg doxylamine succinate mg prevention nausea pregnancy withdrawn market reasons safety effectiveness monday april fda approved return doxylaminepyridoxine combination new trademark name diclegis medication manufactured duchesnay inc company later shown disclose conflict interests authors leading canadian family physician correct several articles behavior lack research shows medically significant july drug company came considerable scrutiny promoting drug american celebrity kim kardashian social media platforms facebook october toronto canada physicians drs navindra persaud jessica chin mark walker wrote public letter journal obstetrics gynaecology canada raised concerns risks diclectin recommended reconsidering firstline pharmacological treatment nausea vomiting dr persaud shared news agencies source research data drug came health canada claimed able access document signing confidentiality january canadian family physician issued correction stating recommendations articles published canadian family physician nausea vomiting pregnancy evidencebased treatment algorithm treatment nausea vomiting pregnancy updated algorithm subsequently come critical scrutiny articles subjected standard peer review canadian family physician acknowledges upon closer inspection articles provide satisfactory evidence would justified recommendation doxylaminepyridoxine sole firstline treatment nausea vomiting pregnancy nvp recent canadian nvp guidelines published however subsequent reanalysis questions conclusions studies cited guidelines justify doxylaminepyridoxine recommended firstline treatment nvp additionally articles canadian family physician undisclosed conflict interest duchesnay manufacturer diclectin combination doxylaminepyridoxine canadian family physician encourages readers interpret previously published nvp recommendations caution readers also referred commentary motherisk canadian family physician january issue canadian family ed bolding help summarize information note please follow link article see footnotes article legal perspective case daubert v merrell dow pharmaceuticals us set new standard admitting expert testimony federal courts lieu frye httpsenwikipediaorgwikipyridoxinedoxylamine